Everest Medicines Completes HK$1.57 Billion Share Placement to Advance R&D and Commercialization
CompanyDeals

Everest Medicines Completes HK$1.57 Billion Share Placement to Advance R&D and Commercialization

Yangtze River Pharmaceutical's Tadalafil Hydrochloride Tablets Approved for ED Treatment in China
CompanyDrug

Yangtze River Pharmaceutical’s Tadalafil Hydrochloride Tablets Approved for ED Treatment in China

Ipsen's Cabometyx Approved by European Commission for Neuroendocrine Tumors
CompanyDrug

Ipsen’s Cabometyx Approved by European Commission for Neuroendocrine Tumors

NHSA Announces Reforms to Centralized Drug Procurement Policies Beyond Lowest Price
Policy / Regulatory

NHSA Announces Reforms to Centralized Drug Procurement Policies Beyond Lowest Price

Boehringer Ingelheim Reports 6.3% Sales Growth in First Half of 2025
Company

Boehringer Ingelheim Reports 6.3% Sales Growth in First Half of 2025

Kelun-Biotech's SKB378/WIN378 Enters Global Phase II Trial for Asthma Treatment
CompanyDrug

Kelun-Biotech’s SKB378/WIN378 Enters Global Phase II Trial for Asthma Treatment

Sirius Therapeutics' SRSD107 Receives EMA Approval for Phase II Clinical Trials in Thromboembolic Diseases
CompanyDrug

Sirius Therapeutics’ SRSD107 Receives EMA Approval for Phase II Clinical Trials in Thromboembolic Diseases

Akeso Enrolls First Patient in Phase III Trial of Ivonescimab for Pancreatic Cancer
CompanyDrug

Akeso Enrolls First Patient in Phase III Trial of Ivonescimab for Pancreatic Cancer

Youcare Pharma's YKYY029 Receives FDA IND Approval for Hypertension Treatment
CompanyDrug

Youcare Pharma’s YKYY029 Receives FDA IND Approval for Hypertension Treatment

National Health Commission Launches Integrated Medical and Elder Care Demonstration Projects
Policy / Regulatory

National Health Commission Launches Integrated Medical and Elder Care Demonstration Projects

Kintor's KX-826 Topical Solution Meets Primary Endpoint in AGA Phase II Trial
CompanyDrug

Kintor’s KX-826 Topical Solution Meets Primary Endpoint in AGA Phase II Trial

Ascentage Pharma Collaborates with Major Chinese Firms to Commercialize Lisaftoclax
CompanyDeals

Ascentage Pharma Collaborates with Major Chinese Firms to Commercialize Lisaftoclax